BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32869685)

  • 41. Treatment of follicular lymphoma.
    Izutsu K
    J Clin Exp Hematop; 2014; 54(1):31-7. PubMed ID: 24942944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter Study.
    Ruella M; Filippi AR; Bruna R; Di Russo A; Magni M; Caracciolo D; Passera R; Matteucci P; Di Nicola M; Corradini P; Parvis G; Gini G; Olivieri A; Ladetto M; Ricardi U; Tarella C; Devizzi L
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):783-91. PubMed ID: 26972651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Follicular lymphoma: an update on diagnosis, prognosis, and management.
    Mozas P; Sorigué M; López-Guillermo A
    Med Clin (Barc); 2021 Nov; 157(9):440-448. PubMed ID: 34210513
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Management strategy for follicular lymphoma].
    Fukuhara N
    Rinsho Ketsueki; 2017; 58(10):2020-2025. PubMed ID: 28978844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Follicular lymphoma: 2020 update on diagnosis and management.
    Freedman A; Jacobsen E
    Am J Hematol; 2020 Mar; 95(3):316-327. PubMed ID: 31814159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Additional therapy improves outcomes in completely resected, limited-stage follicular lymphoma.
    Andraos TY; Ayoub Z; Nastoupil LJ; Milgrom SA; Pinnix CC; Ng SP; Gunther JR; Fowler NH; Neelapu SS; Samaniego F; Fayad LE; Dabaja BS
    Leuk Lymphoma; 2019 Dec; 60(13):3258-3265. PubMed ID: 31234671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combined modality treatment for PET-positive non-Hodgkin lymphoma: favorable outcomes of combined modality treatment for patients with non-Hodgkin lymphoma and positive interim or postchemotherapy FDG-PET.
    Halasz LM; Jacene HA; Catalano PJ; Van den Abbeele AD; Lacasce A; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e647-54. PubMed ID: 22607911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early stage follicular lymphoma, current management and controversies.
    Jacobson CA; Freedman AS
    Curr Opin Oncol; 2012 Sep; 24(5):475-9. PubMed ID: 22820411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of histologic grade and Ki-67 proliferation index in follicular lymphoma.
    Xue T; Yu BH; Yan WH; Jiang XN; Tian T; Zhou XY; Li XQ
    Hematol Oncol; 2020 Dec; 38(5):665-672. PubMed ID: 32627854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era.
    Sesques P; Bourcier J; Golfier C; Lebras L; Nicolas-Virelizier E; Hacini M; Perrin MC; Voillat L; Bachy E; Traverse-Glehen A; Moreau A; Martin L; Ramla S; Casasnovas O; Le Gouill S; Salles G; Ghesquières H
    Hematol Oncol; 2020 Apr; 38(2):137-145. PubMed ID: 31953963
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial.
    Trotman J; Barrington SF; Belada D; Meignan M; MacEwan R; Owen C; Ptáčník V; Rosta A; Fingerle-Rowson GR; Zhu J; Nielsen T; Sahin D; Hiddemann W; Marcus RE; Davies A;
    Lancet Oncol; 2018 Nov; 19(11):1530-1542. PubMed ID: 30309758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.
    Zinzani PL; Pellegrini C; Broccoli A; Casadei B; Argnani L; Pileri S
    Am J Hematol; 2013 Nov; 88(11):E273-6. PubMed ID: 23843267
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcomes after involved-field radiation therapy (IFRT) with or without rituximab in patients with early-stage low-grade non-Hodgkin lymphoma (NHL) staged with CT and PET.
    Lukens JN; Nasta SD; Fram B; Glatstein E; Plastaras JP
    Am J Clin Oncol; 2014 Feb; 37(1):35-40. PubMed ID: 22992623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
    Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
    Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Definitive radiotherapy for localized follicular lymphoma staged by
    Brady JL; Binkley MS; Hajj C; Chelius M; Chau K; Balogh A; Levis M; Filippi AR; Jones M; Mac Manus M; Wirth A; Oguchi M; Vistisen AK; Andraos TY; Ng AK; Aleman BMP; Choi SH; Kirova Y; Hardy S; Reinartz G; Eich HT; Bratman SV; Constine LS; Suh CO; Dabaja B; El-Galaly TC; Hodgson DC; Ricardi U; Yahalom J; Hoppe RT; Mikhaeel NG
    Blood; 2019 Jan; 133(3):237-245. PubMed ID: 30446493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advances in Treatment of Follicular Lymphoma.
    Luminari S; Trotman J; Federico M
    Cancer J; 2020; 26(3):231-240. PubMed ID: 32496456
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Refining the treatment of follicular lymphoma.
    Buske C; Gisselbrecht C; Gribben J; Letai T; McLaughlin P; Wilson W
    Leuk Lymphoma; 2008; 49 Suppl 1():18-26. PubMed ID: 18821429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Follicular lymphoma. High-dose immunochemotherapy with autologous blood stem cell transplantation: Results of the first prospective study in Russia].
    Nesterova ES; Kravchenko SK; Mangasarova YK; Baryakh EA; Misyurina AE; Vorobyev VI; Plastinina LV; Chernova NG; Kovrigina AM; Obukhova TN; Klyasova GA; Shevelev AA; Kostina IE; Gemdzhian EG; Gaponova TV; Vorobyev AI
    Ter Arkh; 2016; 88(7):62-71. PubMed ID: 27459617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nodal follicular lymphoma: the role of radiotherapy for stages I and II.
    Heinzelmann F; Engelhard M; Ottinger H; Bamberg M; Weinmann M
    Strahlenther Onkol; 2010 Apr; 186(4):191-6. PubMed ID: 20354662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma.
    Zhou X; Wang J; Zhang J; Copley-Merriman C; Torigoe Y; Reyes C; Seymour JF; Offner FC; Trneny M; Salles GA
    Hematology; 2015 Apr; 20(3):129-36. PubMed ID: 25029908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.